Characteristics of mesenchymal stem cells derived from Wharton’s jelly of human umbilical cord and for fabrication of non-scaffold tissue-engineered cartilage

by | Jul 16, 2019 | Ankle and Foot, Back Arthritis & Spine disease, Elbow & Hand problems, Hip Problems, Knee Problem, Neck Arthritis & Spine disease, NEW, Orthopedics, Shoulder problems

Characteristics of mesenchymal stem cells derived from Wharton’s jelly of human umbilical cord and for fabrication of non-scaffold tissue-engineered cartilage

Journal of Bioscience and Bioengineering

 

Source

Volume 117, Issue 2, February 2014, Pages 229-235    https://doi.org/10.1016/j.jbiosc.2013.07.001

ShuyunLiu‡ Ke DongHou‡ Mei Yuan, Jiang Peng, LiZ hang, Xiang Sui, Bin Zhao, Wenjing Xu, Aiyuan Wang, Shibi Lu, Quanyi Guo

 

Abstract

Once cartilage is damaged, it has limited potential for self-repair. Autologous chondrocyte implantation is an effective treatment, but patients may suffer during cartilage harvesting and the donor-site morbidity may accelerate joint degeneration. Using autologous mesenchymal stem cells (MSCs) derived chondrocytes is another selection, while it also causes some injuring.

 

Study PDF Link